X-101349934-A-G
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PS1_ModeratePM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000061.3(BTK):c.1931T>C(p.Phe644Ser) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F644L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000061.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BTK | NM_000061.3 | c.1931T>C | p.Phe644Ser | missense_variant | 19/19 | ENST00000308731.8 | |
BTK | NM_001287344.2 | c.2033T>C | p.Phe678Ser | missense_variant | 19/19 | ||
BTK | NM_001287345.2 | c.1403T>C | p.Phe468Ser | missense_variant | 17/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BTK | ENST00000308731.8 | c.1931T>C | p.Phe644Ser | missense_variant | 19/19 | 1 | NM_000061.3 | P3 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
X-linked agammaglobulinemia with growth hormone deficiency Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2023 | This sequence change replaces phenylalanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 644 of the BTK protein (p.Phe644Ser). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with X-linked recessive agammaglobulinemia (PMID: 8695804, 32552675). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 1358012). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BTK protein function. Studies have shown that this missense change alters BTK gene expression (PMID: 8695804). This variant disrupts the p.Phe644 amino acid residue in BTK. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 8695804, 19419768, 32552675). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.